Skip to main content

View full-text article in PMC

. 2023 Feb 21;12(5):269–287. doi: 10.1089/wound.2021.0126

Table 1.

Economic cost and prevalence of inflammatory skin conditions

Disease	Annual U.S. Cost (2021 USD)	Prevalence, %
Psoriasis^182,183	$128 billion	2
Hidradenitis suppurativa^184,185	$2800 per patient	2
Contact dermatitis^37,186	$1.8 billion	20
Pyoderma gangrenosum^43,187	$9.5 million	0.006
Diabetic foot ulcer^188,189	$21 billion	13
Venous stasis ulcer^188,190	$1.7 billion	2
Pressure ulcer^188,191	$25 billion	7
TEN¹⁹²	$56000 per patient	1
Rosacea^186,193	$243 million	5

TEN, toxic epidermal necrolysis.